Canrenone
CAS No. 976-71-6
Canrenone( Aldadiene | NSC 261713 | SC-9376 | SC-14266 )
Catalog No. M16883 CAS No. 976-71-6
A synthetic pregnadiene compound with anti-aldosterone activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
50MG | 35 | In Stock |
|
100MG | 56 | In Stock |
|
200MG | 78 | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCanrenone
-
NoteResearch use only, not for human use.
-
Brief DescriptionA synthetic pregnadiene compound with anti-aldosterone activity.
-
DescriptionA synthetic pregnadiene compound with anti-aldosterone activity.(In Vitro):Canrenone inhibits the production of eortieosterone, 18-hydroxydesoxyeortieosterone, 18-hydroxycorticosterone and aldosterone in a dose-dependent manner. Canrenone dose-dependently reduces platelet-derived growth factor–induced cell proliferation and motility. Canrenone inhibits the activity of the Na+/H+ exchanger 1 induced by platelet-derived growth factor.(In Vivo):Canrenone is the principal active metabolite of Spironolactone in the rat only for a limited period. During chronic treatment a difference developed between the effect of Spironolactone and Canrenone on the RAAS indicating a decrease in the anti-mineralocorticoid activity of Canrenone and an increase in the efficacy of Spironolactone.
-
In VitroCanrenone inhibits the production of eortieosterone, 18-hydroxydesoxyeortieosterone, 18-hydroxycorticosterone and aldosterone in a dose-dependent manner. Canrenone dose-dependently reduces platelet-derived growth factor–induced cell proliferation and motility. Canrenone inhibits the activity of the Na+/H+ exchanger 1 induced by platelet-derived growth factor.
-
In VivoCanrenone is the principal active metabolite of Spironolactone in the rat only for a limited period. During chronic treatment a difference developed between the effect of Spironolactone and Canrenone on the RAAS indicating a decrease in the anti-mineralocorticoid activity of Canrenone and an increase in the efficacy of Spironolactone.
-
SynonymsAldadiene | NSC 261713 | SC-9376 | SC-14266
-
PathwayEndocrinology/Hormones
-
TargetGR
-
RecptorMineralocorticoid Receptor
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number976-71-6
-
Formula Weight340.46
-
Molecular FormulaC22H28O3
-
Purity>98% (HPLC)
-
SolubilityDMSO: > 10 mM
-
SMILESO=C1CC[C@]2(CO3)C4CC[C@]5(C3=O)[C@](O)(CCC(O)=O)CC[C@@]5([H])[C@]4([H])C=CC2=C1
-
Chemical Name3-((8R,10S,13R,14S,17R)-17-hydroxy-3,18-dioxo-2,3,8,9,11,12,14,15,16,17-decahydro-1H-10,13-(methanooxymethano)cyclopenta[a]phenanthren-17-yl)propanoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Derosa G, et al. Ann Med. 2015 Feb;47(1):47-52.
molnova catalog
related products
-
Canrenone
A synthetic pregnadiene compound with anti-aldosterone activity.
-
AZD-7594
AZD-7594 (AZ-13189620) is a potent, nonsteroidal, selective glucocorticoid receptor modulator (SGRM) with binding IC50 of 0.9 nM.
-
Flumethasone
Flumethasone is a glucocorticoid receptor agonist, this complex binds to the nucleus causing a variety of genetic activation and repressions.